Logo.jpg
Multiple Sclerosis Market To Reach USD 39.9 Billion By 2032, Report By DataHorizzon Research
April 25, 2024 08:50 ET | DataHorizzon Research
Fort Collins, Colorado, April 25, 2024 (GLOBE NEWSWIRE) -- Rise in cases of multiple sclerosis to trigger the need for vaccines and diagnosis. Multiple sclerosis (MS) is a condition characterized...
Final Logo-01.png
Multiple Sclerosis Market is estimated to be US$ 32.9 billion by 2032; Rising Early Diagnosis and Advancements in Treatment to Boost Market Growth – BY PMI
October 25, 2023 14:00 ET | PMI
Covina, Oct. 25, 2023 (GLOBE NEWSWIRE) -- What is multiple sclerosis, and how does it affect patients? Multiple Sclerosis is often categorized into different clinical forms. The most common...
SNS-INSIDER-300X300.jpg
Multiple Sclerosis (MS) Market to Cross USD 28.21 Billion by 2030 due to Rising Prevalence of Multiple Sclerosis (MS) and Favorable Reimbursement Policies | Research by SNS Insider
May 10, 2023 09:15 ET | SNS Insider pvt ltd
Pune, May 10, 2023 (GLOBE NEWSWIRE) -- “The Multiple Sclerosis (MS) Market was valued at USD 23.2 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 2.2% over the...
Global Neurological Biomarkers Market
Global Neurological Biomarkers Market Report 2022 to 2028: Featuring Bio-Rad Laboratories, Merck, PerkinElmer and Shimadzu Among Others
March 21, 2023 11:33 ET | Research and Markets
Dublin, March 21, 2023 (GLOBE NEWSWIRE) -- The "Global Neurological Biomarkers Market Size, Share & Industry Trends Analysis Report by Type (Proteomic, Genomic, Metabolomic), Application...
mrf.jpg
Multiple Sclerosis Treatment Market Size to Surpass USD 30.55 Billion by 2030 at 2.31% CAGR – Report by Market Research Future (MRFR)
February 15, 2023 09:00 ET | Market Research Future
New York, USA, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Multiple Sclerosis Treatment Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Multiple Sclerosis...
22157.jpg
Multiple Sclerosis Global Market Analysis: Historical Data 2016-2020 and Forecasts for 2021-2026
February 25, 2022 04:03 ET | Research and Markets
Dublin, Feb. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Market - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country: Market Insights,...
22157.jpg
Global Multiple Sclerosis Industry Review 2018-2020 with Forecasts to 2026 - Market Size by Country, Competitor Drug Sales, Market Shares, and More
December 24, 2021 06:58 ET | Research and Markets
Dublin, Dec. 24, 2021 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. This report provides...
22157.jpg
Global Multiple Sclerosis Drugs Market Report 2021: Market is Expected to Reach $25.95 Billion in 2025 - Long-term Forecast to 2030
December 13, 2021 06:53 ET | Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Drugs Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. ...
FBI LOGO TM.png
Multiple Sclerosis Drugs Market Worth $40.66 Bn at 7.1% CAGR; Industry Bigwigs Such as Novartis and Biogen to Focus on Introducing Cost-Effective MS Treatments: Fortune Business Insights™
August 24, 2020 07:56 ET | Fortune Business Insights
Pune, Aug. 24, 2020 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is projected to reach USD 40.66 billion by 2027, exhibiting a CAGR of 7.1% during the forecast period. ...
FBI LOGO TM.png
Multiple Sclerosis Drugs Market to Hit USD 40.66 Bn by 2027; Promising Research into Developing Efficient MS Therapies to Prove Beneficial for the Market: Fortune Business Insights™
July 30, 2020 12:00 ET | Fortune Business Insights
Pune, July 30, 2020 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is projected to reach USD 40.66 billion by 2027, exhibiting a CAGR of 7.1% during the forecast period. High...